
==== Front
Commun Med (Lond)
Commun Med (Lond)
Communications Medicine
2730-664X
Nature Publishing Group UK London

39300237
607
10.1038/s43856-024-00607-7
Article
A population-based study of familial coaggregation and shared genetic etiology of psychiatric and gastrointestinal disorders
Pan Yi-Jiun 1
Lin Mei-Chen 2
Liou Jyh-Ming 345
Fan Chun-Chieh 67
Su Mei-Hsin 89
Chen Cheng-Yun 8
Wu Chi-Shin 210
Chen Pei-Chun 2
Huang Yen-Tsung 11
http://orcid.org/0000-0002-8466-2698
Wang Shi-Heng shwang@nhri.edu.tw

212
1 https://ror.org/00v408z34 grid.254145.3 0000 0001 0083 6092 Department of Microbiology and Immunology, School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan
2 https://ror.org/02r6fpx29 grid.59784.37 0000 0004 0622 9172 National Center for Geriatrics and Welfare Research, National Health Research Institutes, Zhunan, Taiwan
3 https://ror.org/03nteze27 grid.412094.a 0000 0004 0572 7815 Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
4 https://ror.org/05bqach95 grid.19188.39 0000 0004 0546 0241 Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan
5 https://ror.org/05bqach95 grid.19188.39 0000 0004 0546 0241 Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan
6 https://ror.org/05e6pjy56 grid.417423.7 0000 0004 0512 8863 Center for Population Neuroscience and Genetics, Laureate Institute for Brain Research, Tulsa, OK USA
7 grid.266100.3 0000 0001 2107 4242 Department of Radiology, School of Medicine, University of California San Diego, La Jolla, CA USA
8 https://ror.org/00v408z34 grid.254145.3 0000 0001 0083 6092 Department of Public Health, College of Public Health, China Medical University, Taichung, Taiwan
9 https://ror.org/02nkdxk79 grid.224260.0 0000 0004 0458 8737 Department of Psychiatry, Virginia Institute for Psychiatric Behavioral Genetics, Virginia Commonwealth University, Richmond, VA USA
10 https://ror.org/03nteze27 grid.412094.a 0000 0004 0572 7815 Department of Psychiatry, National Taiwan University Hospital, Yunlin branch, Douliu, Taiwan
11 https://ror.org/05bxb3784 grid.28665.3f 0000 0001 2287 1366 Institute of Statistical Science, Academia Sinica, Taipei, Taiwan
12 grid.254145.3 0000 0001 0083 6092 Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan
19 9 2024
19 9 2024
2024
4 1808 5 2024
5 9 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Background

It has been proposed that having a psychiatric disorder could increase the risk of developing a gastrointestinal disorder, and vice versa. The role of familial coaggregation and shared genetic loading between psychiatric and gastrointestinal disorders remains unclear.

Methods

This study used the Taiwan National Health Insurance Research Database; 4,504,612 individuals born 1970–1999 with parental information, 51,664 same-sex twins, and 3,322,959 persons with full-sibling(s) were enrolled. Genotyping was available for 106,796 unrelated participants from the Taiwan Biobank. A logistic regression model was used to examine the associations of individual history, affected relatives, and polygenic risk scores (PRS) for schizophrenia (SCZ), bipolar disorder (BPD), major depressive disorder (MDD), and obsessive-compulsive disorder (OCD), with the risk of peptic ulcer disease (PUD), gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD), and vice versa.

Results

Here we show that parental psychiatric disorders are associated with gastrointestinal disorders. Full-siblings of psychiatric cases have an increased risk of gastrointestinal disorders except for SCZ/BPD and IBD; the magnitude of coaggregation is higher in same-sex twins than in full-siblings. The results of bidirectional analyses mostly remain unchanged. PRS for SCZ, MDD, and OCD are associated with IBS, PUD/GERD/IBS/IBD, and PUD/GERD/IBS, respectively. PRS for PUD, GERD, IBS, and IBD are associated with MDD, BPD/MDD, SCZ/BPD/MDD, and BPD, respectively.

Conclusions

There is familial coaggregation and shared genetic etiology between psychiatric and gastrointestinal comorbidity. Individuals with psychiatric disorder-affected relatives or with higher genetic risk for psychiatric disorders should be monitored for gastrointestinal disorders, and vice versa.

Plain language summary

It has been proposed that people with psychiatric disorders such as depression could have an increased chance of developing gastrointestinal disorders such as irritable bowel syndrome. We looked at whether this was the case in a large number of people from Taiwan. We found that people with a psychiatric disorder, or with relatives having a psychiatric disorder, were more likely to have gastrointestinal disorders, and vice versa. These findings suggest that people who have psychiatric disorders or have psychiatric disorder-affected relatives should be monitored for gastrointestinal disorders, and vice versa, to enable them to benefit from all the treatments they might need to improve their health.

Pan et al. examine whether there is a shared pathophysiological mechanism underlying brain-gut comorbidity. This population-based cohort and biobank study demonstrates that there is familial coaggregation and shared genetic etiology between psychiatric and gastrointestinal comorbidity.

Subject terms

Gastroenterology
Genetic association study
https://doi.org/10.13039/501100004737 National Health Research Institutes (NHRI) NHRI-EX109-10931PI, NHRI-EX110-10931PI, NHRI-EX111-10931PI Wang Shi-Heng issue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcIntroduction

Accumulating evidence from observational studies suggests that psychiatric disorders could increase the risk of gastrointestinal disorders, and vice versa1–25. However, existing epidemiological literature has focused on few pairs of psychiatric and gastrointestinal disorders; a comprehensive assessment of the brain-gut comorbidity is warranted. In addition to bidirectional causality behind the brain-gut comorbidity evidenced from Mendelian randomization analyses26,27, the comorbidity may be due to a shared genetic etiology.

Exploring the extent of familial coaggregation between the two disorders may provide insights into the underlying etiology of their comorbidities that could imply shared genetic loadings or environmental factors. A family history of psychiatric disorders was associated with irritable bowel syndrome (IBS)28; individuals with parental IBS and inflammatory bowel disease (IBD) have a higher risk of major depressive disorder (MDD)29, and autism, respectively30. Examining the extent of familial coaggregation in relatives with varying degrees of genetic similarity and comparing the strength of recurrence association could provide further insights23,31. We expect that the association would be greater in closer relatives and the risk would be higher in individuals with more affected relatives, which would support the existence of shared genetic background for comorbidity.

Genome-wide association studies (GWAS) have identified the susceptibility loci for psychiatric disorders32–37 and gastrointestinal disorders, and these large-scale GWASs have been performed in populations of European majority26,38–45. Based on GWAS summary, a significant positive genetic correlation exists between psychiatric and gastrointestinal disorders26,27,43,45,46 and several shared susceptibility loci have been identified with pleiotropic effects26,40,45,47,48 in European populations. Although the efforts to understand the genetic mechanism behind the brain-gut comorbidity are promising, these results based on predominantly molecular genetic studies may be affected by extreme sampling of cases and thus require more replication. However, to our knowledge, no population-based familial study comparing varying degrees of genetic similarity with sufficient statistical power has evaluated the issue. In addition, culture behaviors could vary across populations, and the genetic correlations between human complex traits may vary across populations and cultures49. Although the genetic correlation behind the comorbid relationship between psychiatric and gastrointestinal diseases has been proposed in European populations using summary statistics, whether it could be replicated in different cultured populations remained unclear.

This study aimed to investigate comorbidity, familial coaggregation and shared genetic loading between four common psychiatric disorders in adults with publicly available GWAS summary and good validity in health insurance databases, including schizophrenia (SCZ), bipolar disorder (BPD), MDD, and obsessive-compulsive disorder (OCD), and four common gastrointestinal disorders with publicly available GWAS summary, including peptic ulcer disease (PUD), gastroesophageal reflux disease (GERD), IBS, and IBD, by performing a population-based cohort study and biobank study. First, we explored within-individual comorbidity and within-family coaggregation, in which relatives with varying degrees of genetic similarity were considered, using data from Taiwan’s single-payer compulsory insurance program. Second, we explored the association of polygenic risk score (PRS)50 for psychiatric disorders with gastrointestinal disorders, and vice versa, among a large collection of genome-wide genotyping data of community participants from the Taiwan Biobank. Third, we explored the genetic correlation between psychiatric and gastrointestinal disorders using GWAS summary statistics. We also explored bidirectional causal associations (vertical pleiotropy) between psychiatric and gastrointestinal disorders by Mendelian randomization analyses.

Here we show that there is familial coaggregation and shared genetic etiology between psychiatric and gastrointestinal comorbidity. Individuals with psychiatric disorder-affected relatives or with higher genetic risk for psychiatric disorders should be monitored for gastrointestinal disorders, and vice versa.

Methods

We conducted a nationwide cohort study using the National Health Insurance Research Database (NHIRD) and a molecular genetic study using the Taiwan Biobank, linking the genotyping information to NHIRD. The study described in this paper was approved by the Institutional Review Board (IRB) of the Central Regional Research Ethics Committee of the China Medical University, Taichung, Taiwan (CRREC-108-30); the requirement for informed consent to have been obtained from all participants of the NHIRD whose data was included was waived because the NHIRD contains de-identified data.

The National Health Insurance (NHI) of Taiwan, a single-payer health insurance system, was initiated in 1995 and covers more than 99% of the Taiwanese population. The NHI’s claims data are released as the NHIRD, held by the Ministry of Health and Welfare, Taiwan. Informed consent was not obtained from people whose data is included in the NHIRD because the data is de-identified. Before requesting access to the NHIRD for research purposes, researchers must receive an approval from the IRB. The IRB and the Ministry of Health and Welfare, Taiwan approved our application to access the NHIRD.

The data collection of Taiwan Biobank was approved by the Ethics and Governance Council of Taiwan Biobank and the Ministry of Health and Welfare, Taiwan. Taiwan Biobank obtained informed consent from all participants for research use of the collected data and samples and the linkage with the NHIRD. The IRB, the Ministry of Health and Welfare, Taiwan, and the Taiwan Biobank approved our application to access the cross-linkage data of Taiwan Biobank and NHIRD.

Cohort study subjects and measurements

We integrated several databases from the NHIRD. Registry for beneficiaries contains information on the identifiers of the relationships between insured person and their dependents. Only spouses and blood relatives are eligible as dependents of an insured person. We used the covered-insurance relationship to infer pedigree relationships, and the accuracy of the inferred pedigree is excellent51. Using the Registry for Beneficiaries, as described by Wang et al.51, family information was ascertained based on the information of the identifiers and unique personal identifier numbers of the parent, child, grandparent, grandchild, and spouse. Indirect identification of the pedigree was further performed based on the above-mentioned direct identification. We selected families wherein the parent and child had an age difference of at least 12 years to maximize the probability to obtain correct familial relatedness. Siblings were defined as two individuals having the same parents. Twins were defined as two individuals being born on the same day and from the same parents; however, monozygotic and dizygotic twins could not be distinguished. Triplets were not included in this study. Death certifications were used to follow up the vital status of the study population. Inpatient and outpatient claims data were used to identify disease diagnoses.

We identified psychiatric and gastrointestinal disorders using inpatient and outpatient claims data from 1998 to the date of death or until the end of 2020. Detailed information for identifying psychiatric and gastrointestinal disorders on the International Classification of Diseases codes is presented in Supplementary Table 1. At least two outpatient or one inpatient admission for a disease were considered, to increase diagnostic precision. Comorbidity was defined if having more than one disease during the follow-up duration.

Biobank study subjects and measurements

The Taiwan Biobank52,53, the largest government-supported biobank in Taiwan since 2012, recruits community-based participants aged 30–70 years with no history of cancer. Each participant provided blood samples and attended face-to-face interviews.

This study comprised 131,048 individuals for whom genome-wide genotyping was carried out using the custom Taiwan Biobank chips ran on the Axiom Genome-Wide Array Plate System (Affymetrix, Santa Clara, CA, USA); 27,716 participants were genotyped on theTWBv1 chip and 103,332 participants genotyped on theTWBv2 chip. Quality control was performed for the two batches separately before imputation, including the exclusion of variants with a call rate <5%, minor allele frequency <0.001, and deviation from Hardy-Weinberg equilibrium with p < 1E-06. As described in our prior paper54, we used the 504 EAS panel from 1000 Genomes Project55 and the 973 TWB panel from whole-genome sequencing in TWB participants as the reference panel to impute the genotypes with IMPUTE2 for the two batches separately (16,537,409 variants for TWBv1 batch and 16,211,759 variants for TWBv2 batch) and then retained variants with imputation info > 0.7 (13,803,412 variants for TWBv1 batch and 13,572,189 variants for TWBv2 batch). A total of 12,601,684 variants were available in both batches and kept for subsequent PRS calculation.

As described in our prior paper54, duplicated samples, non-EAS samples, as well as samples with a missing rate of more than 2%, or heterozygosity outliers (exceeding 5 standard deviations) were excluded, and 128,775 samples remained. Principal components analysis was performed to account for population stratification, and top 20 principal components (PCs) were included in the model for adjustment. To remove cryptic relatedness, we estimated the identity by descent (IBD) sharing coefficients (PI-HAT = probability (IBD = 2) + 0.5 × Probability (IBD = 1)) between any two participants. For pair-wise participants with PI-HAT > 0.1875, one of the study participants was removed; 106,806 unrelated participants were kept. Finally, 106,796 unrelated participants were successfully linked to NHIRD to retrieve their disease diagnoses and included in the subsequent PRS analysis.

We derived PRS for four psychiatric and four gastrointestinal disorders using PRS-CSx (if large-scale GWAS summary was available in both European and East Asian populations)56, or PRS-CS57. The PRS was normalized to a Z-score and categorized into deciles for ease of interpretation.

Data from the Psychiatric Genomics Consortium (PGC) meta-analysis were used as a discovery sample to identify the risk variants for SCZ, BPD, MDD, and OCD, and the PRS for each corresponding psychiatric disorder was calculated in the Taiwan Biobank. To optimize the PRS prediction, we derived PRS for SCZ using PRS-CSx56, a state-of-the-art Bayesian polygenic modeling method jointly modeling GWAS summary statistics of different discovery samples, to integrate GWAS in 22778 cases and 35362 controls of East Asian descent35 and GWAS in 53,386 cases and 77,258 controls of European descent37, which lead to a better prediction than the PRS derived from GWAS of 67,390 cases and 94,015 controls of European descent majority37 in our target samples. We derived PRS for MDD using PRS-CSx to integrate GWAS in 13,042 cases and 88,467 controls of East Asian descent33 and GWAS in 246363 cases and 561190 controls of European descent34, which led to a better prediction than the PRS derived from the European GWAS only. The PRS for BPD was derived from a discovery sample of 41,917 cases and 371,549 controls of European descent36 using PRS-CS57, a polygenic prediction method inferring posterior effect sizes of susceptibility variants by utilizing a high-dimensional Bayesian regression framework and continuous shrinkage priors on susceptibility variant effect sizes. The PRS for OCD was derived from a discovery sample of 2688 cases and 7037 controls of European descent32 using PRS-CS.

The PRS for PUD was derived from a discovery sample of 16,666 cases and 439,661 controls of European descent26 using PRS-CS. The PRS for GERD was derived from a discovery sample of 78,707 cases and 288,734 controls of European descent43 using PRS-CS. The PRS for IBS was derived from a discovery sample of 53,400 cases and 433,201 controls of European descent45 using PRS-CS. The PRS for IBD was derived from a discovery sample of 25,042 cases and 34,915 controls of European descent44 using PRS-CS.

Covariates considered in the biobank study included BMI, education attainment, lifestyles, and diet habits. Educational attainment was classified as elementary school and below, junior high school, senior high/vocational school, university/college, and master and above. Lifestyles included lifetime regular smoking (persisted > 6 months), lifetime regular drinking (>150 cc weekly, persisting for >6 months), and exercise habits. Diet habits included tea and coffee consumption, vegetarian, and late-night supper.

Statistics and Reproducibility

The distribution of demographic factors, psychiatric disorders, and gastrointestinal disorders was described by numbers and percentages. Generalized estimating equations with an exchangeable working correlation structure were used to consider the non-independence of data within the family cluster in all analyses. A generalized linear model with binomial distribution and logistic link function was used to estimate the adjusted ORs and 95% CIs.

To evaluate the within-individual association, in which individuals with a psychiatric disorder were more likely to have comorbid gastrointestinal disorders compared with population controls, and vice versa, sex, birth cohort, age (length of follow-up), income level, and urbanization level were adjusted.

To investigate familial coaggregation between psychiatric and gastrointestinal disorders, we examined whether individuals with affected relatives, including parents, same-sex twins, and full siblings, with a psychiatric disorder are more likely to have gastrointestinal disorders than individuals with unaffected relatives, and vice versa.

Parental history of psychiatric/gastrointestinal disorder was categorized as both parents without disease history (P−M−, reference group), maternal history only (P−M+), paternal history only (P+M−), and both parents with disease history (P+M+). To evaluate the strength of the association between parental psychiatric/gastrointestinal disorders and those of the children, the first adjustment model included sex, birth cohort, age, income level, urbanization level, father’s age, and mother’s age. The second adjustment model further included the outcome individual’s self-corresponding psychiatric/gastrointestinal diagnosis.

Regarding the history of psychiatric/gastrointestinal disorder in full siblings, two categorized methods were applied; first, any sibling with the disease vs. no disease (reference group); second, no disease (reference group), 1, and ≥ 2 siblings with the disease to explore the dose-response relationship. To evaluate the strength of sibling coaggregation, the first adjustment model included sex, birth cohort, age, income level, urbanization level, sibling’s age, and sibling size, while the second adjustment model further included the outcome individual’s self-corresponding psychiatric/gastrointestinal diagnosis. To evaluate the strength of the coaggregation within same-sex twins, the adjustment was similar, except for sibling age and size. A higher OR in same-sex twins than in full siblings provides evidence for shared genetic influences on the coaggregation of psychiatric and gastrointestinal disorders.

Sex-stratified analyses for within-individual association and within-family associations were estimated to explore sex differences.

To study shared polygenetic liability, we tested the association of PRS for psychiatric disorders with gastrointestinal disorders, and vice versa, among 106,796 unrelated individuals. The significance of each PRS was evaluated using logistic regression models adjusted for sex, age, batch version, and the first 20 principal components58,59. To evaluate the robust of the PRS association, several potential confounders were further adjusted; first, BMI, education attainment, and lifestyles were additionally adjusted, and second, diet habit was further adjusted. Dummy variable adjustment was used for handling missing data. To further explore the pure effect of PRS, individuals with a corresponding psychiatric/gastrointestinal disorder were excluded from PRS testing. A total of 106,127; 105,071; 92,828; and 106,276 eligible individuals were tested for PRS for SCZ; BPD; MDD; and OCD, respectively, while 61,571; 74,104; 91,739; and 104,151 eligible individuals were tested for PRS for PUD; GERD; IBS; and IBD, respectively. Sex differences in the PRS association were tested.

Linkage disequilibrium (LD) score regression60,61 using European reference panel was used to estimate the genetic correlation between psychiatric and gastrointestinal disorders.

Bidirectional Mendelian randomization analyses were performed to examine the causality between psychiatric and gastrointestinal disorders. To extract independent variants, LD clumping was conducted based on r2 > 0.0001 within a 1000 kb window. Variants with genome-wide significance (p < 5 × 10−8) for exposure were selected as genetic instruments. The fixed-effect inverse variance weighted method62 was considered as main analysis. Several Mendelian randomization methods were used for the sensitivity analysis, including MR-Egger63, weighted median64, weighted mode65, and MR PRESSO66.

The significance level was set at 0.05. Considering 16 testing scenarios (four psychiatric disorders times four gastrointestinal disorders), the significance level was set at a Bonferroni-corrected 0.003125. All statistical analyses were performed using SAS statistical package (version 9.4, SAS Institute Inc., Cary, NC, USA).

Reporting summary

Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.

Results

Cohort description

Altogether 4,504,612 eligible individuals from 2,536,631 families born between January 1, 1970, and December 31, 1999, with information regarding both parents, were included in this study, and they were followed up from 1998 to 2020 to examine individual associations and parental associations. After excluding 10,325 triplets, 13,296 opposite-sex twins, and 1,106,368 single children, 51,664 same-sex twins (monozygotic and dizygotic twins could not be distinguished) and 3,322,959 full sibling(s) from 1,409,874 families were enrolled.

The distribution of demographic characteristics, psychiatric disorders, and gastrointestinal disorders is presented in Supplementary Table 2. The proportion of men in the total cohort was 52.9%. The prevalence of PUD, GERD, IBS, and IBD were 12.6%, 13.1%, 5.8%, and 3.1%, respectively. The prevalence of SCZ, BPD, MDD, and OCD were 0.9%, 1.1%, 6.1%, and 0.5%, respectively. Sex-stratified prevalence is shown in Supplementary Table 3.

Within-individual and within-family associations

The distribution of comorbidities of psychiatric and gastrointestinal disorders in the total cohort is presented in Supplementary Table 4. Individuals with a psychiatric disorder had increased comorbidity with gastrointestinal disorders, and the odds ratio (OR) ranged from 1.2 to 2.9 (Fig. 1, detailed number in Supplementary Table 4).Fig. 1 Individual history and family history, including parents, same-sex twins, and full siblings, of psychiatric disorders and the risk of gastrointestinal disorders.

a schizophrenia (SCZ). b Bipolar disorder (BPD). c Major depressive disorder (MDD). d Obsessive-compulsive disorder (OCD). Odds ratio and 95% confidence interval represents the association estimated in the within-individual analyses and in within-family analysis of different types of relatives. Green triangle indicates peptic ulcer disease (PUD), orange diamond indicates gastroesophageal reflux disease (GERD), blue square indicates irritable bowel syndrome (IBS), and pink circle indicates inflammatory bowel disease (IBD). The sample size for analyses of individual history and parental history = 4,504,612, same-sex twins = 51,664, and full siblings = 3,322,959.

The distribution and associations of the family history of psychiatric disorders and risks of gastrointestinal disorders for parents/same-sex twins/full siblings are detailed in Supplementary Data 1–4. After further adjusting for the outcome individual’s self-psychiatric diagnosis, the OR attenuated slightly and remained similar, implying that within-family association was not predominantly attributable to the within-individual association. The ORs for the outcome person’s gastrointestinal disorders across the family history of psychiatric disorders in different relatives are plotted in Fig. 1.

Generally, parental history of psychiatric disorders was associated with a higher risk for gastrointestinal disorders, and the magnitude of the association for P+M+ (OR, 1.2–2.1) was higher than that for P+M−/P−M+ (OR, 1.1–1.5).

Full sibling of SCZ patients had an increased risk of PUD, GERD, and IBS (OR = 1.13, 1.08, and 1.19, respectively). The magnitude of association for those with ≥ 2 SCZ-affected siblings was higher than those with one SCZ-affected sibling.

Full siblings of BPD patients had an increased risk of PUD, GERD, and IBS (OR = 1.25, 1.19, and 1.22, respectively) in a dose-response manner, while same-sex twins (OR = 1.82, 1.43, and 1.35, respectively) had a greater association than full siblings.

Full siblings of patients with MDD had an increased risk of PUD, GERD, IBS, and IBD (OR = 1.22, 1.17, 1.21, and 1.09, respectively), with a dose-response relationship between the number of MDD-affected siblings and the risk of four gastrointestinal disorders. Same-sex twins (OR = 1.40, 1.32, and 1.37 for PUD, GERD, and IBS, respectively) had a greater association than full siblings.

Same-sex twins of patients with OCD had an increased risk of PUD, GERD, and IBS (OR = 1.51, 1.29, and 1.95, respectively); full siblings of patients with OCD had an increased risk of PUD, GERD, IBS, and IBD (OR = 1.23, 1.28, 1.47, and 1.16, respectively), and in a dose-response manner for PUD and IBS.

Bi-directional analyses

Conversely, the associations between the history of gastrointestinal disorders and risks of psychiatric disorders for self/parental/same-sex twins/full siblings are presented in Fig. 2 (detailed in Supplementary Table 5 and Supplementary Data 5–8). Parental PUD and GERD were associated with BPD/MDD/OCD (OR, 1.1–1.2) but not with SCZ. Parental IBS was associated with SCZ/BPD/MDD (OR, 1.1–1.2) and OCD (OR, 1.3–1.4). Parental IBD was not associated with any psychiatric disorder. The bidirectional results for same-sex twins and full siblings were similar (Figs. 1, 2).Fig. 2 Individual history and family history, including parents, same-sex twins, and full siblings, of gastrointestinal disorders and the risk of psychiatric disorders.

a Peptic ulcer disease (PUD). b Gastroesophageal reflux disease (GERD). c Irritable bowel syndrome (IBS). d Inflammatory bowel disease (IBD). Odds ratio and 95% confidence interval represent the association estimated in the within-individual analyses and in within-family analysis of different types of relatives. Purple triangle indicates schizophrenia (SCZ), gray diamond indicates bipolar disorder (BPD), pink square indicates major depressive disorder (MDD), and brown circle indicates obsessive-compulsive disorder (OCD). The sample size for analyses of individual history and parental history = 4,504,612, same-sex twins = 51,664, and full siblings = 3,322,959.

Sex-stratified analyses

Sex-stratified within-individual and within-family associations of psychiatric disorders with the risk of gastrointestinal disorders are presented in Supplementary Fig 1 (detailed numbers in Supplementary Data 9). Generally, the sex-specific estimates for within-family associations were similar. The sex-stratified association of gastrointestinal disorders with the risk of psychiatric disorders is presented in Supplementary Fig. 2 (detailed numbers in Supplementary Data 10).

Individual-level PRS association in biobank study

The distribution of demographic characteristics and psychiatric and gastrointestinal disorders among the 106,796 biobank participants is shown in Supplementary Table 6. The PRS for psychiatric disorders (2.05%, 0.31%, 0.55%, and 0.04% for SCZ, BPD, MDD, and OCD, respectively) explained a higher variance in the corresponding disease status compared to the PRS for gastrointestinal disorders (0.04%, 0.23%, 0.08%, and 0.01% for PUD, GERD, IBS, and IBD, respectively) (Supplementary Table 7).

The results of the association of PRS for psychiatric and gastrointestinal disorders are shown in Supplementary Table 8. SCZ PRS was positively associated with IBS (OR per standard deviation (SD) increase in PRS: 1.03, 95% confidence interval (CI): 1.01–1.05, p = 0.001). BPD PRS was not associated with any gastrointestinal disorder. MDD PRS was positively associated with PUD (OR = 1.06, 95% CI: 1.04–1.07, p < 1E-16), GERD (OR = 1.07, 95% CI: 1.05–1.08, p < 1E-16), IBS (OR = 1.07, 95% CI: 1.05–1.09, p = 2E-11), and IBD (OR = 1.06, 95% CI: 1.02–1.10, p = 0.005; less than Bonferroni-corrected significance). OCD PRS was positively associated with PUD (OR = 1.02, 95% CI: 1.00–1.03, p = 0.01; less than Bonferroni-corrected significance), GERD (OR = 1.02, 95% CI: 1.01–1.03, p = 0.004; less than Bonferroni-corrected significance), and IBS (OR = 1.03, 95% CI: 1.01–1.05, p = 0.001). For the deciles of PRS with the lowest as a reference, the ORs between PRS for psychiatric and gastrointestinal disorders are plotted in Fig. 3 for visualization (detailed numbers in Supplementary Data 11).Fig. 3 Association of decile of polygenic risk score (PRS) for psychiatric disorders with gastrointestinal disorders.

a Schizophrenia (SCZ). b Bipolar disorder (BPD). c Major depressive disorder (MDD). d Obsessive-compulsive disorder (OCD). Odds ratio and 95% confidence interval for the highest nine deciles, respectively, compared to the lowest decile. Green triangle indicates peptic ulcer disease (PUD), orange diamond indicates gastroesophageal reflux disease (GERD), blue square indicates irritable bowel syndrome (IBS), and pink circle indicates inflammatory bowel disease (IBD). Sample size = 106,796.

PUD PRS was associated with MDD (OR = 1.03, 95% CI: 1.01–1.05, p = 0.002). GERD PRS was associated with BPD (OR = 1.08, 95% CI: 1.03–1.14, p = 0.003) and MDD (OR = 1.11, 95% CI: 1.09–1.14, p < 1E-16). IBS PRS was associated with SCZ (OR = 1.08, 95% CI: 1.00–1.17, p = 0.04; less than Bonferroni-corrected significance), BPD (OR = 1.07, 95% CI: 1.02–1.12, p = 0.007; less than Bonferroni-corrected significance), and MDD (OR = 1.06, 95% CI: 1.05–1.08, p = 4E-13). IBD PRS was associated with BPD (OR = 1.05, 95% CI: 1.00–1.11, p = 0.03; less than Bonferroni-corrected significance). The ORs between deciles of PRS for gastrointestinal and psychiatric disorders are plotted in Fig. 4 (detailed numbers in Supplementary Data 12).Fig. 4 Association of decile of polygenic risk score (PRS) for gastrointestinal disorders with psychiatric disorders.

a Peptic ulcer disease (PUD). b Gastroesophageal reflux disease (GERD). c Irritable bowel syndrome (IBS). d Inflammatory bowel disease (IBD). Odds ratio and 95% confidence interval for the highest nine deciles, respectively, compared to the lowest decile. Purple triangle indicates schizophrenia (SCZ), gray diamond indicates bipolar disorder (BPD), pink square indicates major depressive disorder (MDD), and brown circle indicates obsessive-compulsive disorder (OCD). Sample size = 106,796.

Adjusting several potential confounders, including body mass index (BMI), education attainment, and lifestyles (smoking, drinking, and exercise habit) did not substantively affect the PRS results (Supplementary Table 9). Further adjusting diet habit (including tea and coffee consumption, vegetarian, and late-night supper) also did not affect the results. After excluding individuals with a corresponding psychiatric/gastrointestinal disorder based on PRS, the results remained similar (Supplementary Table 10).

Modest sex differences, less than Bonferroni-corrected significance, were detected in PRS associations (Supplementary Table 11). SCZ PRS was associated with PUD in males but not in females. BPD PRS was associated with IBS in females but not in males. The effect of MDD PRS on IBS was greater in females than in males.

Summary statistics-based genetic correlation

The genetic correlations between psychiatric and gastrointestinal disorders are shown in Fig. 5. There was a small positive genetic correlation (rg range, 0.11–0.15) between SCZ and IBS/IBD, BPD and GERD/IBS, and MDD and IBD. There was a modest positive genetic correlation (rg range, 0.47–0.62) between MDD and PUD/GERD/IBS.Fig. 5 Genetic correlations between psychiatric disorders and gastrointestinal disorders.

The value indicates the rg estimate. *indicates p < 0.05; **indicates p < 0.003125. schizophrenia (SCZ); bipolar disorder (BPD); major depressive disorder (MDD); obsessive-compulsive disorder (OCD); peptic ulcer disease (PUD); gastroesophageal reflux disease (GERD); irritable bowel syndrome (IBS); inflammatory bowel disease (IBD).

Mendelian randomization and causal association

Bidirectional causal associations (vertical pleiotropy) between psychiatric and gastrointestinal disorders using inverse variance weighted method are presented in Supplementary Fig 3. Genetically predicted MDD was associated with a higher risk of PUD, GERD, and IBS. Genetically predicted GERD and IBS was associated with a higher risk of MDD. Genetically predicted SCZ was associated with IBD. The results from alternative Mendelian randomization methods were generally consistent (Supplementary Data 13).

Discussion

This study explored the underlying mechanisms of brain-gut comorbidity using three complementary approaches: testing comorbidity and familial coaggregation in different relatives, examining individual-level shared polygenetic loading, and evaluating the summary statistics-based genetic correlation and bidirectional causality between four psychiatric and four gastrointestinal disorders. Triangulating evidence from these analyses revealed familial coaggregation and a shared genetic etiology.

To our knowledge, this is the largest nationwide cohort study and one of the first studies to comprehensively explore shared genetic etiology underlying psychiatric and gastrointestinal comorbidity. Different complementary study designs were used in this study. Our findings of shared genetic etiology behind the brain-gut comorbidity in Taiwanese of East Asian populations replicated a recent study46 in European populations, which purely dependent on GWAS summary. Our study used large-scale individual health insurance data and individual genotyping data to perform comorbid, familial coaggregation and shared polygenic loading analyses in East Asian populations. Our nationwide cohort study has several unique characteristics, including no ascertainment bias because of the extensive coverage rate and large sample size (more than 4.5 million subjects). Our biobank study, with more than 130,000 community participants, used the latest GWAS discovery sample and state-of-the-art Bayesian method to optimize PRS prediction and polygenic association. Several potential confounders have been considered in the PRS association tests. Moreover, the disease information was identified with ICD diagnoses using the linkage to NHIRD rather than retrospective self-reporting that may lead to recall bias and result in misclassification and underestimation of the prevalence of diseases67.

Within-family analyses suggested that there was familial coaggregation between psychiatric and gastrointestinal disorders and implied a shared mechanism in brain-gut comorbidity. Although this could not rule out shared environmental contributions, the patterns of strength of association in different relatives and in varying numbers of affected relatives provided evidence for shared genetic etiology between psychiatric and gastrointestinal disorders. First, the association was greater in same-sex twins (mixing of monozygotic twins sharing ~100% of genes and dizygotic twins sharing ~50% of genes) than in full siblings (sharing ~50% of genes). Second, the association in full siblings was similar to that in either parent (all shared ~50% of the genes). Third, familial association was greater in two affected siblings than in one affected sibling. Fourth, familial association was greater in both affected parents than in either parent.

Gastrointestinal disorders are multifactorial and correlated with a shared etiological mechanism. Helicobacter pylori infection and pharmacotherapy with nonsteroidal anti-inflammatory drugs are major risk factors that lead to subsequent inflammation and mucosal damage68, although approximately 20% of PUD cases are not related to this69. This implies the importance of other pathogeneses, and the brain-to-gut pathway is an emerging one. In addition, individuals with higher genetic liability for MDD are at a higher risk for PUD and GERD26. This study provided extensive evidence of the influence of genetic liability for a wide range of psychiatric disorders on PUD, GERD, IBS, and IBD.

Our findings that the polygenic association between MDD and gastrointestinal disorders are in line with the genetic correlation between them. The PRS for GERD/IBS/IBD was associated with BPD, which was consistent with the observed genetic correlation between them; however, BPD PRS was not associated with GERD/IBS/IBD. Both PRS analyses and genetic correlation analyses showed no genetic overlap between BPD and PUD, which implied the role of environmental factors in comorbidity and familial coaggregation between them. Our finding that SCZ PRS was associated with IBS, and vice versa, echoed the genetic correlation between SCZ and IBS. Additionally, our results that higher OCD PRS increased the risk for PUD, GERD, and IBS in Taiwanese samples of East Asian populations are novel and important for the understanding of brain-gut comorbidity; the opposite direction for the summary statistics-based genetic correlation between OCD and GERD (not passed Bonferroni correction significance) in European populations may be due to different populations.

The interplay between psychiatric and gastrointestinal disorders implies the importance of developing screening and treatment strategies70. Our analysis of within-individual and within-family association between psychiatric and gastrointestinal disorders suggested that individual and familial psychological factors are important in the development of gastrointestinal disorders, and individuals with psychiatric disorders or with psychiatric disorder-affected relatives should be monitored and screened for gastrointestinal disorders. Psychiatric interventions, such as antidepressants and psychological therapies were effective in the treatment of gastrointestinal disorders16,17,71. Conversely, the effect of treatment for gastrointestinal disorders on psychiatric comorbidity was summarized71.

Psychological stress induces systemic and mucosal proinflammatory responses72, increases small intestinal permeability73, and triggers gastrointestinal symptoms and disorders74,75. Vice versa, gut microbial dysbiosis influences brain chemistry and contributes to psychiatric disorder76–78. Our PRS analyses further suggested that pleiotropy contributed to brain-gut comorbidity, and the association of psychiatric PRS with a gastrointestinal disorder might be attributed to psychological suffering in individuals with a higher genetic load for psychiatric disorders. In our within-family analyses, parental SCZ was associated with PUD/GERD and parental BPD/MDD was associated with IBD; however, reversely, these trans-generational associations were not observed. This implied that parental psychiatric disorders could create a stressful family environment that affects gut health. Adequate prevention and treatment of psychological distress may be crucial for gut health.

Psychological stress triggers and exacerbates immune-mediated symptoms and diseases79. By contrast, immune processes are involved in the development of psychiatric disorders80. GWAS have identified immune loci and multiple immune signaling pathways enriched for psychiatric risk47,81. Shared genetic loadings between psychiatric disorders and immune-mediated diseases, such as IBD23,27,30, suggested the role of immune dysfunction in the central nervous system.

Sex differences in psychiatric/gastrointestinal disorders have been documented82,83, but sex differences in brain-gut comorbidity have not been adequately explored. The within-family association of family history of MDD in full siblings with PUD risk was larger in females. In addition, we observed that the effect of PRS for BPD and MDD on IBS was greater in females. A GWAS on IBS has also identified female-specific susceptibility loci42, which have been linked to sex-specific traits and sex hormones. Sex hormones have an influence on gastrointestinal functions83–85. Sex hormones and other hormones could contribute to regulatory signals along the axis of brain-gut interactions and influence gut motor function and mucosal immune activation84,86.

This study has some limitations. First, the cohort study used NHIRD between 1998 and 2020 to follow-up the study samples and identify their diseases; only individuals, including the study samples and their relatives, who were alive during the study period, were included. Disease diagnoses were missed if they did not use any medical services during the catchment period. Second, given the uncertainty in establishing the exact disease onset time using national insurance claims (the onset can have left-censoring if it was earlier than the study start year of 1997) and the extensiveness of diagnostic ascertainment (99% of the coverage), the cumulative incidence is a more stable metric than instantaneous incidence; hence, we decided to perform logistic regression, which is robust to the characteristics of our data, rather than the Cox model. Future studies should ascertain the onset time and estimate the risk trajectories and order between the comorbidity of psychiatric and gastrointestinal disorders. Third, the sample size for both parents were affected (P+M+) and same-sex twins was relatively limited, and it resulted in wider confidence interval estimates. Fourth, genetic architecture differs across populations; hence, using cross-ancestry GWAS results to derive PRS could lower predictive variance87. The discovery sample used in this study was mainly of European ancestry, and we applied the PRS-CS/PRS-CSx to improve cross-population polygenic prediction in Asian samples. In addition, PRS only considers common variants and thus captures only limited heritability estimated from family studies. Fifth, the recruited biobank participants were not representative of the population; hence, selection bias for healthy volunteers was possible. Nevertheless, a valid assessment of the genetic associations may be generalizable. Sixth, medications and microbiomes were not considered in this study, and their role, as confounders, mediators, modifiers, or prognostic factors, in comorbidity and shared genetic architecture between psychiatric disorders and gastrointestinal disorders should be further studied. Finally, we only included individuals of Taiwanese ancestry in family-based and PRS analyses. Therefore, further investigations are warranted to determine whether our findings can be generalized to other populations.

In conclusion, our population-based cohort and biobank study showed that there was familial coaggregation and shared genetic etiology behind the co-occurrence of psychiatric and gastrointestinal disorders. Thus, efforts to elucidate the mechanisms of brain-gut comorbidity have implications for prevention and therapeutic planning.

Supplementary information

Peer Review File

Supplementary Information

Description of Additional Supplementary Files

Supplementary data

Reporting Summary

Supplementary information

The online version contains supplementary material available at 10.1038/s43856-024-00607-7.

Acknowledgements

This work was supported by National Health Research Institutes (NHRI-EX109-10931PI, NHRI-EX110-10931PI, NHRI-EX111-10931PI), National Science and Technology Council (NSTC111-2628-B-400-004-MY3) and China Medical University, Taiwan (CMU112-S-46; CMU112-MF-22).

Author contributions

Research idea: P.J. Pan, S.H. Wang; Study design and supervision: S.H. Wang; Data analysis: M.C. Lin, M.H. Su, C.Y. Chen, S.H. Wang; Interpretation of results: J.M. Liou, C.C. Fan, C.S. Wu, P.C. Chen, Y.T. Huang; Drafting of manuscript: P.J. Pan, S.H. Wang; Critical comments and editing of manuscript drafts: M.C. Lin, J.M. Liou, C.C. Fan, M.H. Su, C.Y. Chen, C.S. Wu, P.C. Chen, Y.T. Huang; Approval of final submitted manuscript: P.J. Pan, M.C. Lin, J.M. Liou, C.C. Fan, M.H. Su, C.Y. Chen, C.S. Wu, P.C. Chen, Y.T. Huang, S.H. Wang.

Peer review

Peer review information

This manuscript has been previously reviewed at another Nature Portfolio journal. The manuscript was considered suitable for publication without further review at Communications Medicine. A peer review file is available.

Data availability

Publicly available data are available from the following sites: GWAS summary results for psychiatric diseases were downloaded from https://www.med.unc.edu/pgc/; GWAS summary results for PUD were downloaded from https://cnsgenomics.com/content/data; GWAS summary results for GERD were downloaded from http://ftp.ebi.ac.uk/pub/databases/gwas/summary_statistics/GCST90000001-GCST90001000/GCST90000514/; GWAS summary results for IBS were downloaded from http://ftp.ebi.ac.uk/pub/databases/gwas/summary_statistics/GCST90016001-GCST90017000/GCST90016564/; GWAS summary results for IBD were downloaded from http://ftp.ebi.ac.uk/pub/databases/gwas/summary_statistics/GCST004001-GCST005000/GCST004131/. The NHIRD used in this study is held by the Taiwan Ministry of Health and Welfare and under controlled access. Researchers interested in accessing the data set can submit an application form to the Ministry of Health and Welfare requesting access. Taiwan Biobank data used in this study is under controlled access. Application to access can be made to the Taiwan Biobank. All other data are available from the corresponding author on reasonable request. The source data for Fig. 1 is in Supplementary Table 4 and Supplementary Data 1–4. The source data for Fig. 2 is in Supplementary Table 5 and Supplementary Data 5–8. The source data for Fig. 3 is in Supplementary Data 11. The source data for Fig. 4 is in Supplementary Data 12.

Code availability

The code used in this study is available from the following websites: PRS-CSx: https://github.com/getian107/PRScsx (10.1038/s41588-022-01054-7)56; PRS-CS: https://github.com/getian107/PRScs (10.1038/s41467-019-09718-5)57; LD score regression: https://github.com/bulik/ldsc (10.1038/ng.3211 and 10.1038/ng.3406)60,61.

Competing interests

The authors declare no competing interests.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Bernstein CN Increased burden of psychiatric disorders in inflammatory bowel disease Inflamm. Bowel Dis. 2019 25 360 368 10.1093/ibd/izy235 29986021
Bernstein, C. N. et al. Increased burden of psychiatric disorders in inflammatory bowel disease. Inflamm. Bowel Dis. 25, 360–368 (2019).29986021
2. Umar N The association between inflammatory bowel disease and mental ill health: a retrospective cohort study using data from UK primary care Aliment Pharm. Ther. 2022 56 814 822 10.1111/apt.17110
Umar, N. et al. The association between inflammatory bowel disease and mental ill health: a retrospective cohort study using data from UK primary care. Aliment Pharm. Ther. 56, 814–822 (2022).
3. Malaspina D Advancing paternal age and the risk of schizophrenia Arch. Gen. Psychiatry 2001 58 361 367 10.1001/archpsyc.58.4.361 11296097
Malaspina, D. et al. Advancing paternal age and the risk of schizophrenia. Arch. Gen. Psychiatry 58, 361–367 (2001).11296097
4. Ludvigsson JF Association between inflammatory bowel disease and psychiatric morbidity and suicide: a Swedish nationwide population-based cohort study with sibling comparisons J. Crohns Colitis 2021 15 1824 1836 10.1093/ecco-jcc/jjab039 33640971
Ludvigsson, J. F. et al. Association between inflammatory bowel disease and psychiatric morbidity and suicide: a Swedish nationwide population-based cohort study with sibling comparisons. J. Crohns Colitis 15, 1824–1836 (2021).33640971
5. Arp L Jansson S Wewer V Burisch J Psychiatric disorders in adult and paediatric patients with inflammatory bowel diseases–a systematic review and meta-analysis J. Crohns Colitis 2022 16 1933 1945 10.1093/ecco-jcc/jjac095 35775920
Arp, L., Jansson, S., Wewer, V. & Burisch, J. Psychiatric disorders in adult and paediatric patients with inflammatory bowel diseases–a systematic review and meta-analysis. J. Crohns Colitis 16, 1933–1945 (2022).35775920
6. Barberio B Zamani M Black CJ Savarino EV Ford AC Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis Lancet Gastroenterol. Hepatol. 2021 6 359 370 10.1016/S2468-1253(21)00014-5 33721557
Barberio, B., Zamani, M., Black, C. J., Savarino, E. V. & Ford, A. C. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 6, 359–370 (2021).33721557
7. Jansson C Severe gastro‐oesophageal reflux symptoms in relation to anxiety, depression and coping in a population‐based study Aliment Pharm. Ther. 2007 26 683 691 10.1111/j.1365-2036.2007.03411.x
Jansson, C. et al. Severe gastro‐oesophageal reflux symptoms in relation to anxiety, depression and coping in a population‐based study. Aliment Pharm. Ther. 26, 683–691 (2007).
8. Shah E Rezaie A Riddle M Pimentel M Psychological disorders in gastrointestinal disease: epiphenomenon, cause or consequence? Ann. Gastroenterol. 2014 27 224 230 24974805
Shah, E., Rezaie, A., Riddle, M. & Pimentel, M. Psychological disorders in gastrointestinal disease: epiphenomenon, cause or consequence? Ann. Gastroenterol. 27, 224–230 (2014).24974805
9. Jones MP Mood and anxiety disorders precede development of functional gastrointestinal disorders in patients but not in the population Clin. Gastroenterol. Hepatol. 2017 15 1014 1020 10.1016/j.cgh.2016.12.032 28087404
Jones, M. P. et al. Mood and anxiety disorders precede development of functional gastrointestinal disorders in patients but not in the population. Clin. Gastroenterol. Hepatol. 15, 1014–1020 (2017).28087404
10. Lee Y-T Risk of psychiatric disorders following irritable bowel syndrome: a nationwide population-based cohort study PloS ONE 2015 10 e0133283 10.1371/journal.pone.0133283 26222511
Lee, Y.-T. et al. Risk of psychiatric disorders following irritable bowel syndrome: a nationwide population-based cohort study. PloS ONE 10, e0133283 (2015).26222511
11. Lin W-S Gastroesophageal reflux disease and risk for bipolar disorder: a nationwide population-based study PloS ONE 2014 9 e107694 10.1371/journal.pone.0107694 25255080
Lin, W.-S. et al. Gastroesophageal reflux disease and risk for bipolar disorder: a nationwide population-based study. PloS ONE 9, e107694 (2014).25255080
12. Sung KY Schizophrenia and risk of new‐onset inflammatory bowel disease: a nationwide longitudinal study Aliment Pharm. Ther. 2022 55 1192 1201 10.1111/apt.16856
Sung, K. Y. et al. Schizophrenia and risk of new‐onset inflammatory bowel disease: a nationwide longitudinal study. Aliment Pharm. Ther. 55, 1192–1201 (2022).
13. Turna J Higher prevalence of irritable bowel syndrome and greater gastrointestinal symptoms in obsessive-compulsive disorder J. Psychiatr. Res. 2019 118 1 6 10.1016/j.jpsychires.2019.08.004 31437616
Turna, J. et al. Higher prevalence of irritable bowel syndrome and greater gastrointestinal symptoms in obsessive-compulsive disorder. J. Psychiatr. Res. 118, 1–6 (2019).31437616
14. Wojczynski MK North KE Pedersen NL Sullivan PF Irritable bowel syndrome: a co-twin control analysis Am. J. Gastroenterol. 2007 102 2220 2229 10.1111/j.1572-0241.2007.01479.x 17897337
Wojczynski, M. K., North, K. E., Pedersen, N. L. & Sullivan, P. F. Irritable bowel syndrome: a co-twin control analysis. Am. J. Gastroenterol. 102, 2220–2229 (2007).17897337
15. You Z-H Risk of psychiatric disorders following gastroesophageal reflux disease: a nationwide population-based cohort study Eur. J. Intern. Med. 2015 26 534 539 10.1016/j.ejim.2015.05.005 26021838
You, Z.-H. et al. Risk of psychiatric disorders following gastroesophageal reflux disease: a nationwide population-based cohort study. Eur. J. Intern. Med. 26, 534–539 (2015).26021838
16. Ford AC Talley NJ Schoenfeld PS Quigley EM Moayyedi P Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis Gut 2009 58 367 378 10.1136/gut.2008.163162 19001059
Ford, A. C., Talley, N. J., Schoenfeld, P. S., Quigley, E. M. & Moayyedi, P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 58, 367–378 (2009).19001059
17. Gracie DJ Hamlin PJ Ford AC The influence of the brain–gut axis in inflammatory bowel disease and possible implications for treatment Lancet Gastroenterol. Hepatol. 2019 4 632 642 10.1016/S2468-1253(19)30089-5 31122802
Gracie, D. J., Hamlin, P. J. & Ford, A. C. The influence of the brain–gut axis in inflammatory bowel disease and possible implications for treatment. Lancet Gastroenterol. Hepatol. 4, 632–642 (2019).31122802
18. Gracie DJ Guthrie EA Hamlin PJ Ford AC Bi-directionality of brain–gut interactions in patients with inflammatory bowel disease Gastroenterology 2018 154 1635 1646 10.1053/j.gastro.2018.01.027 29366841
Gracie, D. J., Guthrie, E. A., Hamlin, P. J. & Ford, A. C. Bi-directionality of brain–gut interactions in patients with inflammatory bowel disease. Gastroenterology 154, 1635–1646 (2018).29366841
19. Kim SY Bidirectional association between gastroesophageal reflux disease and depression: two different nested case-control studies using a national sample cohort Sci. Rep. 2018 8 11748 10.1038/s41598-018-29629-7 30082758
Kim, S. Y. et al. Bidirectional association between gastroesophageal reflux disease and depression: two different nested case-control studies using a national sample cohort. Sci. Rep. 8, 11748 (2018).30082758
20. Kim SY Min C Oh DJ Choi HG Reciprocal association between depression and peptic ulcers: Two longitudinal follow-up studies using a national sample cohort Sci. Rep. 2020 10 1749 10.1038/s41598-020-58783-0 32020020
Kim, S. Y., Min, C., Oh, D. J. & Choi, H. G. Reciprocal association between depression and peptic ulcers: Two longitudinal follow-up studies using a national sample cohort. Sci. Rep. 10, 1749 (2020).32020020
21. Koloski NA The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study Gut 2012 61 1284 1290 10.1136/gutjnl-2011-300474 22234979
Koloski, N. A. et al. The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut 61, 1284–1290 (2012).22234979
22. Sexton KA Evidence of bidirectional associations between perceived stress and symptom activity: a prospective longitudinal investigation in inflammatory bowel disease Inflamm. Bowel Dis. 2017 23 473 483 10.1097/MIB.0000000000001040 28221251
Sexton, K. A. et al. Evidence of bidirectional associations between perceived stress and symptom activity: a prospective longitudinal investigation in inflammatory bowel disease. Inflamm. Bowel Dis. 23, 473–483 (2017).28221251
23. Mataix-Cols D A total-population multigenerational family clustering study of autoimmune diseases in obsessive–compulsive disorder and Tourette’s/chronic tic disorders Mol. Psychiatry 2018 23 1652 1658 10.1038/mp.2017.215 29133949
Mataix-Cols, D. et al. A total-population multigenerational family clustering study of autoimmune diseases in obsessive–compulsive disorder and Tourette’s/chronic tic disorders. Mol. Psychiatry 23, 1652–1658 (2018).29133949
24. Lee YB The association between peptic ulcer diseases and mental health problems: A population-based study: a STROBE compliant article Medicine 2017 96 e7828 10.1097/MD.0000000000007828 28834889
Lee, Y. B. et al. The association between peptic ulcer diseases and mental health problems: A population-based study: a STROBE compliant article. Medicine 96, e7828 (2017).28834889
25. Fadgyas-Stanculete M Buga A-M Popa-Wagner A Dumitrascu DL The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations J. Mol. Psychiatry 2014 2 1 7 10.1186/2049-9256-2-4 25408912
Fadgyas-Stanculete, M., Buga, A.-M., Popa-Wagner, A. & Dumitrascu, D. L. The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations. J. Mol. Psychiatry 2, 1–7 (2014).25408912
26. Wu Y GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal disorders and depression Nat. Commun. 2021 12 1 17 33397941
Wu, Y. et al. GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal disorders and depression. Nat. Commun. 12, 1–17 (2021).33397941
27. Tylee DS An atlas of genetic correlations and genetically informed associations linking psychiatric and immune-related phenotypes JAMA Psychiatry 2022 79 667 676 10.1001/jamapsychiatry.2022.0914 35507366
Tylee, D. S. et al. An atlas of genetic correlations and genetically informed associations linking psychiatric and immune-related phenotypes. JAMA Psychiatry 79, 667–676 (2022).35507366
28. Knight JR Locke GR III Zinsmeister AR Schleck CD Talley NJ Family history of mental illness or alcohol abuse and the irritable bowel syndrome J. Psychosom. Res 2015 78 237 241 10.1016/j.jpsychores.2014.11.021 25582802
Knight, J. R., Locke, G. R. III, Zinsmeister, A. R., Schleck, C. D. & Talley, N. J. Family history of mental illness or alcohol abuse and the irritable bowel syndrome. J. Psychosom. Res 78, 237–241 (2015).25582802
29. Yeh T-C Risks of major mental disorders and irritable bowel syndrome among the offspring of parents with irritable bowel syndrome: a nationwide study Int J. Environ. Res. Public Health 2021 18 4679 10.3390/ijerph18094679 33924787
Yeh, T.-C. et al. Risks of major mental disorders and irritable bowel syndrome among the offspring of parents with irritable bowel syndrome: a nationwide study. Int J. Environ. Res. Public Health 18, 4679 (2021).33924787
30. Sadik, A., et al. Parental inflammatory bowel disease and autism in children. Nat. Med. 28, 1–6 (2022).
31. Ghirardi L The familial co-aggregation of ASD and ADHD: a register-based cohort study Mol. Psychiatry 2018 23 257 262 10.1038/mp.2017.17 28242872
Ghirardi, L. et al. The familial co-aggregation of ASD and ADHD: a register-based cohort study. Mol. Psychiatry 23, 257–262 (2018).28242872
32. Arnold PD Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis Mol. Psychiatry 2018 23 1181 1188 10.1038/mp.2017.154 28761083
Arnold, P. D. et al. Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis. Mol. Psychiatry 23, 1181–1188 (2018).28761083
33. Giannakopoulou O The genetic architecture of depression in individuals of East Asian ancestry: a genome-wide association study JAMA Psychiatry 2021 78 1258 1269 10.1001/jamapsychiatry.2021.2099 34586374
Giannakopoulou, O. et al. The genetic architecture of depression in individuals of East Asian ancestry: a genome-wide association study. JAMA Psychiatry 78, 1258–1269 (2021).34586374
34. Howard DM Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions Nat. Neurosci. 2019 22 343 352 10.1038/s41593-018-0326-7 30718901
Howard, D. M. et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat. Neurosci. 22, 343–352 (2019).30718901
35. Lam, M., et al. Comparative genetic architectures of schizophrenia in East Asian and European populations. Nat. Genet. 10.1038/s41588-41019-40512-x (2019).
36. Mullins N Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology Nat. Genet 2021 53 817 829 10.1038/s41588-021-00857-4 34002096
Mullins, N. et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat. Genet 53, 817–829 (2021).34002096
37. Trubetskoy V Mapping genomic loci implicates genes and synaptic biology in schizophrenia Nature 2022 604 502 508 10.1038/s41586-022-04434-5 35396580
Trubetskoy, V. et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature 604, 502–508 (2022).35396580
38. Tanikawa C A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population Nat. Genet. 2012 44 430 10.1038/ng.1109 22387998
Tanikawa, C. et al. A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population. Nat. Genet. 44, 430 (2012).22387998
39. Ek WE Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts Gut 2015 64 1774 1782 10.1136/gutjnl-2014-307997 25248455
Ek, W. E. et al. Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts. Gut 64, 1774–1782 (2015).25248455
40. An J Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases Nat. Commun. 2019 10 1 10 30602773
An, J. et al. Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases. Nat. Commun. 10, 1–10 (2019).30602773
41. Holliday EG Genome-wide association study identifies two novel genomic regions in irritable bowel syndrome Am. J. Gastroenterol. 2014 109 770 772 10.1038/ajg.2014.56 24797007
Holliday, E. G. et al. Genome-wide association study identifies two novel genomic regions in irritable bowel syndrome. Am. J. Gastroenterol. 109, 770–772 (2014).24797007
42. Bonfiglio F Female-specific association between variants on chromosome 9 and self-reported diagnosis of irritable bowel syndrome Gastroenterology 2018 155 168 179 10.1053/j.gastro.2018.03.064 29626450
Bonfiglio, F. et al. Female-specific association between variants on chromosome 9 and self-reported diagnosis of irritable bowel syndrome. Gastroenterology 155, 168–179 (2018).29626450
43. Ong J-S Multitrait genetic association analysis identifies 50 new risk loci for gastro-oesophageal reflux, seven new loci for Barrett’s oesophagus and provides insights into clinical heterogeneity in reflux diagnosis Gut 2022 71 1053 1061 10.1136/gutjnl-2020-323906 34187846
Ong, J.-S. et al. Multitrait genetic association analysis identifies 50 new risk loci for gastro-oesophageal reflux, seven new loci for Barrett’s oesophagus and provides insights into clinical heterogeneity in reflux diagnosis. Gut 71, 1053–1061 (2022).34187846
44. De Lange KM Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease Nat. Genet. 2017 49 256 261 10.1038/ng.3760 28067908
De Lange, K. M. et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat. Genet. 49, 256–261 (2017).28067908
45. Eijsbouts C Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders Nat. Genet. 2021 53 1543 1552 10.1038/s41588-021-00950-8 34741163
Eijsbouts, C. et al. Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders. Nat. Genet. 53, 1543–1552 (2021).34741163
46. Gong W Role of the gut-brain axis in the shared genetic etiology between gastrointestinal tract diseases and psychiatric disorders: a genome-wide pleiotropic analysis JAMA Psychiatry 2023 80 360 370 10.1001/jamapsychiatry.2022.4974 36753304
Gong, W. et al. Role of the gut-brain axis in the shared genetic etiology between gastrointestinal tract diseases and psychiatric disorders: a genome-wide pleiotropic analysis. JAMA Psychiatry 80, 360–370 (2023).36753304
47. Pouget JG The emerging immunogenetic architecture of schizophrenia Schizophr. Bull. 2018 44 993 1004 10.1093/schbul/sby038 29701842
Pouget, J. G. The emerging immunogenetic architecture of schizophrenia. Schizophr. Bull. 44, 993–1004 (2018).29701842
48. Uellendahl-Werth F Cross-tissue transcriptome-wide association studies identify susceptibility genes shared between schizophrenia and inflammatory bowel disease Commun. Biol. 2022 5 1 15 10.1038/s42003-022-03031-6 34987157
Uellendahl-Werth, F. et al. Cross-tissue transcriptome-wide association studies identify susceptibility genes shared between schizophrenia and inflammatory bowel disease. Commun. Biol. 5, 1–15 (2022).34987157
49. Elgart M Correlations between complex human phenotypes vary by genetic background, gender, and environment Cell Rep. Med. 2022 3 100844 10.1016/j.xcrm.2022.100844 36513073
Elgart, M. et al. Correlations between complex human phenotypes vary by genetic background, gender, and environment. Cell Rep. Med. 3, 100844 (2022).36513073
50. Purcell SM Common polygenic variation contributes to risk of schizophrenia and bipolar disorder Nature 2009 460 748 752 10.1038/nature08185 19571811
Purcell, S. M. et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748–752 (2009).19571811
51. Wang, S.-H., et al. Paternal age and 13 psychiatric disorders in the offspring: a population-based cohort study of 7 million children in Taiwan. Mol Psychiatry 27, 1–11 (2022).
52. Chen C-H Population structure of Han Chinese in the modern Taiwanese population based on 10,000 participants in the Taiwan Biobank project Hum. Mol. Genet. 2016 25 5321 5331 27798100
Chen, C.-H. et al. Population structure of Han Chinese in the modern Taiwanese population based on 10,000 participants in the Taiwan Biobank project. Hum. Mol. Genet. 25, 5321–5331 (2016).27798100
53. Fan C-T Lin J-C Lee C-H Taiwan Biobank: a project aiming to aid Taiwan’s transition into a biomedical island Pharmacogenomics 2008 9 235 246 10.2217/14622416.9.2.235 18370851
Fan, C.-T., Lin, J.-C. & Lee, C.-H. Taiwan Biobank: a project aiming to aid Taiwan’s transition into a biomedical island. Pharmacogenomics 9, 235–246 (2008).18370851
54. Liao S-F Associations of polygenic risks, depression, and obesity-related traits in Taiwan Biobank J. Affect Disord. 2023 320 397 403 10.1016/j.jad.2022.09.149 36206878
Liao, S.-F. et al. Associations of polygenic risks, depression, and obesity-related traits in Taiwan Biobank. J. Affect Disord. 320, 397–403 (2023).36206878
55. Genomes Project Consortium. A global reference for human genetic variation Nature 2015 526 68 74 10.1038/nature15393 26432245
Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68–74 (2015).26432245
56. Ruan Y Improving polygenic prediction in ancestrally diverse populations Nat. Genet. 2022 54 573 580 10.1038/s41588-022-01054-7 35513724
Ruan, Y. et al. Improving polygenic prediction in ancestrally diverse populations. Nat. Genet. 54, 573–580 (2022).35513724
57. Ge T Chen C-Y Ni Y Feng Y-CA Smoller JW Polygenic prediction via Bayesian regression and continuous shrinkage priors Nat. Commun. 2019 10 1776 10.1038/s41467-019-09718-5 30992449
Ge, T., Chen, C.-Y., Ni, Y., Feng, Y.-C. A. & Smoller, J. W. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat. Commun. 10, 1776 (2019).30992449
58. Price AL Principal components analysis corrects for stratification in genome-wide association studies Nat. Genet. 2006 38 904 909 10.1038/ng1847 16862161
Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).16862161
59. Price AL Zaitlen NA Reich D Patterson N New approaches to population stratification in genome-wide association studies Nat. Rev. Genet. 2010 11 459 463 10.1038/nrg2813 20548291
Price, A. L., Zaitlen, N. A., Reich, D. & Patterson, N. New approaches to population stratification in genome-wide association studies. Nat. Rev. Genet. 11, 459–463 (2010).20548291
60. Bulik-Sullivan B An atlas of genetic correlations across human diseases and traits Nat. Genet. 2015 47 1236 1241 10.1038/ng.3406 26414676
Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236–1241 (2015).26414676
61. Bulik-Sullivan BK LD Score regression distinguishes confounding from polygenicity in genome-wide association studies Nat. Genet. 2015 47 291 295 10.1038/ng.3211 25642630
Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).25642630
62. Burgess S Butterworth A Thompson SG Mendelian randomization analysis with multiple genetic variants using summarized data Genet. Epidemiol. 2013 37 658 665 10.1002/gepi.21758 24114802
Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37, 658–665 (2013).24114802
63. Bowden J Davey Smith G Burgess S Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression Int J. Epidemiol. 2015 44 512 525 10.1093/ije/dyv080 26050253
Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J. Epidemiol. 44, 512–525 (2015).26050253
64. Bowden J Davey Smith G Haycock PC Burgess S Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator Genet. Epidemiol. 2016 40 304 314 10.1002/gepi.21965 27061298
Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304–314 (2016).27061298
65. Hartwig F Davey Smith G Bowden J Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption Int. J. Epidemiol. 2017 46 1985 1998 10.1093/ije/dyx102 29040600
Hartwig, F., Davey Smith, G. & Bowden, J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int. J. Epidemiol. 46, 1985–1998 (2017).29040600
66. Verbanck M Chen C Neale B Do R Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases Nat. Genet. 2018 50 693 698 10.1038/s41588-018-0099-7 29686387
Verbanck, M., Chen, C., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50, 693–698 (2018).29686387
67. Su MH Familial aggregation and shared genetic loading for major psychiatric disorders and type 2 diabetes Diabetologia 2022 65 800 810 10.1007/s00125-022-05665-x 35195735
Su, M. H. et al. Familial aggregation and shared genetic loading for major psychiatric disorders and type 2 diabetes. Diabetologia 65, 800–810 (2022).35195735
68. Lanas A Chan FK Peptic ulcer disease Lancet 2017 390 613 624 10.1016/S0140-6736(16)32404-7 28242110
Lanas, A. & Chan, F. K. Peptic ulcer disease. Lancet 390, 613–624 (2017).28242110
69. Charpignon C Peptic ulcer disease: one in five is related to neither H elicobacter pylori nor aspirin/NSAID intake Aliment Pharm. Ther. 2013 38 946 954 10.1111/apt.12465
Charpignon, C. et al. Peptic ulcer disease: one in five is related to neither H elicobacter pylori nor aspirin/NSAID intake. Aliment Pharm. Ther. 38, 946–954 (2013).
70. Peppas S The brain-gut axis: psychological functioning and inflammatory bowel diseases J. Clin. Med. 2021 10 377 10.3390/jcm10030377 33498197
Peppas, S. et al. The brain-gut axis: psychological functioning and inflammatory bowel diseases. J. Clin. Med. 10, 377 (2021).33498197
71. Bisgaard, T. H., Allin, K. H., Keefer, L., Ananthakrishnan, A. N. & Jess, T. Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment. Nat. Rev. Gastroenterol. Hepatol. 19, 1–10 (2022).
72. Mawdsley JE Macey MG Feakins RM Langmead L Rampton DS The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis Gastroenterology 2006 131 410 419 10.1053/j.gastro.2006.05.017 16890594
Mawdsley, J. E., Macey, M. G., Feakins, R. M., Langmead, L. & Rampton, D. S. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Gastroenterology 131, 410–419 (2006).16890594
73. Vanuytsel T Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism Gut 2014 63 1293 1299 10.1136/gutjnl-2013-305690 24153250
Vanuytsel, T. et al. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism. Gut 63, 1293–1299 (2014).24153250
74. Fadgyas-Stanculete M Buga A-M Popa-Wagner A Dumitrascu DLJJ o.m.p. The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations J. Mol. Psychiatry 2014 2 1 7 10.1186/2049-9256-2-4 25408912
Fadgyas-Stanculete, M., Buga, A.-M., Popa-Wagner, A. & Dumitrascu, D. L. J. J. o.m.p. The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations. J. Mol. Psychiatry 2, 1–7 (2014).25408912
75. Sun Y Stress triggers flare of inflammatory bowel disease in children and adults Front. Pediatr. 2019 7 432 10.3389/fped.2019.00432 31709203
Sun, Y. et al. Stress triggers flare of inflammatory bowel disease in children and adults. Front. Pediatr. 7, 432 (2019).31709203
76. Bercik P The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice Gastroenterology 2011 141 599 609.e593 10.1053/j.gastro.2011.04.052 21683077
Bercik, P. et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141, 599–609.e593 (2011).21683077
77. Zhuang Z Yang R Wang W Qi L Huang T Associations between gut microbiota and Alzheimer’s disease, major depressive disorder, and schizophrenia J. Neuroinflammation 2020 17 288 10.1186/s12974-020-01961-8 33008395
Zhuang, Z., Yang, R., Wang, W., Qi, L. & Huang, T. Associations between gut microbiota and Alzheimer’s disease, major depressive disorder, and schizophrenia. J. Neuroinflammation 17, 288 (2020).33008395
78. Zhu F Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice Mol. Psychiatry 2020 25 2905 2918 10.1038/s41380-019-0475-4 31391545
Zhu, F. et al. Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice. Mol. Psychiatry 25, 2905–2918 (2020).31391545
79. Dhabhar FS Effects of stress on immune function: the good, the bad, and the beautiful Immunol. Res. 2014 58 193 210 10.1007/s12026-014-8517-0 24798553
Dhabhar, F. S. Effects of stress on immune function: the good, the bad, and the beautiful. Immunol. Res. 58, 193–210 (2014).24798553
80. Dantzer R Neuroimmune interactions: from the brain to the immune system and vice versa Physiol. Rev. 2018 98 477 504 10.1152/physrev.00039.2016 29351513
Dantzer, R. Neuroimmune interactions: from the brain to the immune system and vice versa. Physiol. Rev. 98, 477–504 (2018).29351513
81. Devlin B Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways Nat. Neurosci. 2015 18 199 209 10.1038/nn.3922 25599223
Devlin, B. et al. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat. Neurosci. 18, 199–209 (2015).25599223
82. Houghton LA Age, gender, and women’s health and the patient Gastroenterology 2016 150 1332 1343 10.1053/j.gastro.2016.02.017
Houghton, L. A. et al. Age, gender, and women’s health and the patient. Gastroenterology 150, 1332–1343 (2016).
83. Meleine M Matricon J Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones World J. Gastroenterol. 2014 20 6725 6743 10.3748/wjg.v20.i22.6725 24944465
Meleine, M. & Matricon, J. Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones. World J. Gastroenterol. 20, 6725–6743 (2014).24944465
84. Heitkemper MM Chang L Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome? Gend. Med. 2009 6 152 167 10.1016/j.genm.2009.03.004 19406367
Heitkemper, M. M. & Chang, L. Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome? Gend. Med. 6, 152–167 (2009).19406367
85. Bernstein MT Gastrointestinal symptoms before and during menses in healthy women BMC Women’s Health 2014 14 1 7 10.1186/1472-6874-14-14 24383580
Bernstein, M. T. et al. Gastrointestinal symptoms before and during menses in healthy women. BMC Women’s Health 14, 1–7 (2014).24383580
86. Hogan AM Collins D Baird AW Winter DC Estrogen and its role in gastrointestinal health and disease Int J. Colorectal Dis. 2009 24 1367 1375 10.1007/s00384-009-0785-0 19655153
Hogan, A. M., Collins, D., Baird, A. W. & Winter, D. C. Estrogen and its role in gastrointestinal health and disease. Int J. Colorectal Dis. 24, 1367–1375 (2009).19655153
87. Martin AR Human demographic history impacts genetic risk prediction across diverse populations Am. J. Hum. Genet. 2017 100 635 649 10.1016/j.ajhg.2017.03.004 28366442
Martin, A. R. et al. Human demographic history impacts genetic risk prediction across diverse populations. Am. J. Hum. Genet. 100, 635–649 (2017).28366442
